Literature DB >> 500113

Loss of adjuvanticity in rats for the hyperacute form of allergic encephalomyelitis and for reaginic antibody production in mice of a phenotypic variant of Bordetella pertussis.

A C Wardlaw, R Parton, R K Bergman, J J Munoz.   

Abstract

The adjuvanticity of a phenotypic (C-mode) variant of B. pertussis, known to be deficient in certain immunological and physiopathological properties, was compared to that of the normal (X-mode) strain. The X-mode vaccine was a potent adjuvant for induction of hyperacute experimental allergic encephalomyelitis to guinea-pig spinal cord in Lewis rats whereas C-mode vaccine was inactive. X-mode vaccine was also highly active in the induction of reaginic (both IgE and IgGl) antibodies to ovalbumin in mice while C-mode vaccine caused only a transitory increase in the IgE level. These data support the view that an adjuvant component of B. pertussis, which is probably identical with the histamine-sensitizing and leukocytosis promoting factor, is much diminished in C-mode cells while the lipopolysaccharide adjuvant remains unchanged.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500113      PMCID: PMC1457713     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Biologically active components and properties of Bordetella pertussis.

Authors:  S I Morse
Journal:  Adv Appl Microbiol       Date:  1976       Impact factor: 5.086

2.  A HYPERACUTE FORM OF ALLERGIC ENCEPHALOMYELITIS.

Authors:  S LEVINE; E J WENK
Journal:  Am J Pathol       Date:  1965-07       Impact factor: 4.307

3.  Antigens of Bordetella pertussis. III. The protective antigen.

Authors:  J MUNOZ; B M HESTEKIN
Journal:  Proc Soc Exp Biol Med       Date:  1963-03

4.  The role of Bordetella pertussis as an adjuvant to antibody production.

Authors:  J R FARTHING
Journal:  Br J Exp Pathol       Date:  1961-12

5.  Antigenic modulation of Bordetella pertussis.

Authors:  B W LACEY
Journal:  J Hyg (Lond)       Date:  1960-03

6.  Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis.

Authors:  M Yajima; K Hosoda; Y Kanbayashi; T Nakamura; I Takahashi; M Ui
Journal:  J Biochem       Date:  1978-01       Impact factor: 3.387

7.  Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization.

Authors:  M Yajima; K Hosoda; Y Kanbayashi; T Nakamura; K Nogimori; Y Mizushima; Y Nakase; M Ui
Journal:  J Biochem       Date:  1978-01       Impact factor: 3.387

8.  Role of mouse IgG and IgE homocytotropic antibodies in passive cutaneous anaphylaxis.

Authors:  S B Lehrer
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

9.  Hyperacute allergic encephalomyelitis: adjuvant effect of pertussis vaccines and extracts.

Authors:  S Levine; E J Wenk; H B Devlin; R E Pieroni; L Levine
Journal:  J Immunol       Date:  1966-09       Impact factor: 5.422

10.  A unitarian hypothesis of altered reactivity to stress mediated by Bordetella pertussis.

Authors:  L Levine; R E Pieroni
Journal:  Experientia       Date:  1966-12-15
View more
  2 in total

Review 1.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Modulation of Bordetella pertussis by nicotinic acid.

Authors:  W L McPheat; A C Wardlaw; P Novotny
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.